| scholarly article | Q13442814 |
| editorial | Q871232 |
| P356 | DOI | 10.1016/J.YGYNO.2009.12.009 |
| P698 | PubMed publication ID | 20109724 |
| P50 | author | Anil K. Sood | Q88114757 |
| P2093 | author name string | Robert L Coleman | |
| P2860 | cites work | Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies | Q21091172 |
| Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study | Q28258045 | ||
| Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup | Q30436714 | ||
| Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G | Q33335882 | ||
| Radical trachelectomy and pelvic lymphadenectomy with uterine preservation in the treatment of cervical cancer | Q34172905 | ||
| Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. | Q34374619 | ||
| Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. | Q46792064 | ||
| Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer | Q46892024 | ||
| Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. | Q50512108 | ||
| Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | Q53263238 | ||
| Is radical trachelectomy a safe alternative to radical hysterectomy for patients with stage IA-B carcinoma of the cervix? | Q73254702 | ||
| Abdominal radical trachelectomy: a new surgical technique for the conservative management of cervical carcinoma | Q73794359 | ||
| Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial | Q84574337 | ||
| P433 | issue | 2 | |
| P921 | main subject | gynecologic oncology | Q5625186 |
| P304 | page(s) | 155-156 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Targeted therapy in gynecologic oncology: biology, strategy, and assessment | |
| P478 | volume | 116 |
| Q37923341 | What is the role of chemotherapy in endometrial cancer? | cites work | P2860 |
Search more.